organization · Reporting owner
Curative Ventures V LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Instil Bio, Inc.TIL · Entity 7177 | 10% owner | March 23, 2021 | March 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Instil Bio, Inc.
Report date March 23, 2021 · Filed March 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,980,073 |
Ending reported balance
After 2021-03-23 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-03-23 · Conversion · Acquired 30,000,000 · Balance 30,000,000 F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Row 2 · 2021-03-23 · Conversion · Acquired 6,098,799 · Balance 36,098,799 F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Row 3 · 2021-03-23 · Conversion · Acquired 1,431,274 · Balance 37,530,073 F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Row 4 · 2021-03-23 · Purchase · Acquired 450,000 · Balance 37,980,073 |
| Series A Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-03-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-03-23 · Conversion · Disposed 25,000,000 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. |
| Series B Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-03-23 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-03-23 · Conversion · Disposed 5,082,333 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. |
| Series C Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-03-23 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-03-23 · Conversion · Disposed 1,192,729 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | ConversionSeries C Preferred Stock · Derivative | 1,192,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · derivative · entry 7 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,431,274 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | ConversionSeries B Preferred Stock · Derivative | 5,082,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · derivative · entry 6 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,098,799 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | ConversionSeries A Preferred Stock · Derivative | 25,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · derivative · entry 5 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | PurchaseCommon Stock | 450,000 | $20.00 | $9,000,000.00 |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · nonDerivative · entry 4 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,980,073 Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | ConversionCommon Stock | 1,431,274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · nonDerivative · entry 3 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,530,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | ConversionCommon Stock | 6,098,799 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · nonDerivative · entry 2 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,098,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:29 UTC | Instil Bio, Inc. TIL · Entity 7177 | ConversionCommon Stock | 30,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-023011 · doc4.xml · nonDerivative · entry 1 Curative Ventures V LLC · CIK 0001754072 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.